文献速递产科母胎医学

小于胎龄儿妊娠中胎盘生物标志物与胎儿胎盘多普勒异常与胎盘病理强烈相关:前瞻性研究

Placental biomarker and fetoplacental Doppler abnormalities are strongly associated with placental pathology in pregnancies with small-for-gestational-age fetus: prospective study.
PubMed 文献 · Ultrasound Obstet Gynecol · 2025-05-07

这项前瞻性队列纳入367例小于胎龄儿/胎儿生长受限单胎妊娠,评估脑胎盘率、脐动脉及子宫动脉多普勒、胎盘生长因子和sFlt-1/PlGF比值与胎盘病理的关联。结果显示上述指标异常均与胎盘异常(尤其母体血管灌注不良)几率升高相关。

要点

  • 平均子宫动脉搏动指数>第95百分位与胎盘异常几率升高相关(aOR 5.42)。
  • 脑胎盘率<第5百分位、脐动脉多普勒异常均与胎盘异常及母体血管灌注不良相关。
  • PlGF<100 ng/L和sFlt-1/PlGF比值升高与胎盘异常及母体血管灌注不良相关。

核心结论

  • 在小于胎龄儿/胎儿生长受限妊娠中,平均子宫动脉搏动指数>第95百分位、脐动脉多普勒异常、脑胎盘率<第5百分位、PlGF<100 ng/L及sFlt-1/PlGF比值升高均与胎盘异常强烈相关,尤其是母体血管灌注不良。

研究设计与样本

  • 前瞻性队列研究,纳入澳大利亚昆士兰州Mater Mother's Hospital母胎医学中心的367例小于胎龄儿/胎儿生长受限单胎妊娠。
  • 采用多因素logistic回归并校正子痫前期,评估多普勒指标和胎盘生物标志物与按Amsterdam胎盘工作小组共识标准分类的胎盘异常之间的关联。

主要发现

  • 367例中,母体血管灌注不良159例(43.3%),胎儿血管灌注不良20例(5.4%),不明原因绒毛炎49例(13.4%),绒毛成熟延迟19例(5.2%),慢性组织细胞性 intervillositis 6例(1.6%)。
  • 与多普勒及胎盘生物标志物正常的小于胎龄儿对照相比,脑胎盘率<第5百分位(aOR 3.17,95%CI 1.95-5.16;P<0.001)、脐动脉多普勒异常(aOR 2.97,95%CI 1.80-4.90;P<0.001)、平均子宫动脉搏动指数>第95百分位(aOR 5.42,95%CI 2.75-10.70;P<0.001)与胎盘异常几率升高相关。
  • 母体血管灌注不良的几率在脑胎盘率<第5百分位(aOR 2.47,95%CI 1.64-4.33;P<0.001)、脐动脉多普勒异常(aOR 3.13,95%CI 1.91-5.12;P<0.001)、平均子宫动脉搏动指数>第95百分位(aOR 4.01,95%CI 2.25-7.13;P<0.001)时显著升高。
  • PlGF<100 ng/L(aOR 3.66,95%CI 2.22-6.06;P<0.001)或sFlt-1/PlGF比值升高(aOR 3.74,95%CI 2.17-6.43;P<0.001)时胎盘异常几率亦显著升高;PlGF<100 ng/L(aOR 2.89,95%CI 1.72-4.85;P<0.001)和sFlt-1/PlGF比值升高(aOR 3.15,95%CI 1.83-5.45;P<0.001)时母体血管灌注不良几率亦升高。

关键数值与推荐

  • 脑胎盘率<第5百分位、脐动脉搏动指数>第95百分位或无舒张末期血流/舒张末期血流反向、平均子宫动脉搏动指数>第95百分位。
  • 胎盘生物标志物异常定义:PlGF<100 ng/L;sFlt-1/PlGF比值>5.78(孕龄<28周)或>38(孕龄≥28周)。
  • 胎盘异常按Amsterdam胎盘工作小组共识标准分类:母体血管灌注不良、胎儿血管灌注不良、不明原因绒毛炎、慢性组织细胞性 intervillositis、绒毛成熟延迟。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Placental dysfunction can result in small-for-gestational age (SGA) or fetal growth restriction (FGR). The aim of this prospective cohort study was to assess the association of the cerebroplacental ratio (CPR) and other more conventional fetoplacental Doppler indices, circulating placental growth factor (PlGF) levels and soluble fms-like tyrosine kinase-1 (sFlt-1)/PlGF ratio, with specific placental abnormalities in a large cohort of pregnancies with an SGA/FGR fetus. METHODS: This was a prospective cohort study of singleton pregnancies with a SGA/FGR fetus conducted at the Centre for Maternal and Fetal Medicine at the Mater Mother's Hospital, Queensland, Australia. Multivariable logistic regression with adjustment for pre-eclampsia was used to evaluate the effect of CPR < 5th centile, umbilical artery Doppler abnormality (defined as umbilical artery (UA) pulsatility index (PI) > 95th centile, or absent or reversed end-diastolic flow), mean uterine artery (UtA) PI > 95th centile and abnormal placental biomarkers (PlGF level < 100 ng/L and sFlt-1/PlGF ratio > 5.78 if gestational age < 28 weeks or > 38 if gestational age ≥ 28 weeks) on the following placental abnormalities, classified based on the Amsterdam Placental Workshop Group Consensus criteria: placental maternal vascular malperfusion (MVM), fetal vascular malperfusion (FVM), villitis of unknown etiology (VUE), chronic histiocytic intervillositis (CHI) and delayed villous maturation (DVM). RESULTS: Among the 367 women included in this study, MVM was present in 159 (43.3%) placentae, FVM in 20 (5.4%), VUE in 49 (13.4%), DVM in 19 (5.2%) and CHI in six (1.6%). Compared to SGA controls with normal fetoplacental Doppler and placental biomarkers, CPR < 5th centile (adjusted odds ratio (aOR), 3.17 (95% CI, 1.95-5.16); P < 0.001), abnormal UA Doppler (aOR, 2.97 (95% CI, 1.80-4.90); P < 0.001) and mean UtA-PI > 95th centile (aOR, 5.42 (95% CI 2.75-10.70); P < 0.001) were associated with higher odds of placental abnormality. The odds of MVM specifically were significantly higher when CPR < 5th centile (aOR, 2.47 (95% CI, 1.64-4.33); P < 0.001), abnormal UA Doppler (aOR, 3.13 (95% CI, 1.91-5.12); P < 0.001) or mean UtA-PI > 95th centile (aOR, 4.01 (95% CI, 2.25-7.13); P < 0.001) was present. The odds of placental abnormality were also significantly higher if PlGF levels were < 100 ng/L (aOR, 3.66 (95% CI, 2.22-6.06); P < 0.001) or the sFlt-1/PlGF ratio was elevated (aOR, 3.74 (95% CI, 2.17-6.43); P < 0.001). The odds of MVM were also higher in women with PlGF < 100 ng/L (aOR, 2.89 (95% CI, 1.72-4.85); P < 0.001) and elevated sFlt-1/PlGF ratio (aOR, 3.15 (95% CI, 1.83-5.45); P < 0.001). CONCLUSION: In pregnancies with SGA/FGR fetus, mean UtA-PI > 95th centile, abnormal UA Doppler, CPR < 5th centile, PlGF < 100 ng/L and elevated sFlt-1/PlGF ratio were all strongly associated with placental abnormality, particularly MVM. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Hong J, Crawford K, Cavanagh E, et al. Placental biomarker and fetoplacental Doppler abnormalities are strongly associated with placental pathology in pregnancies with small-for-gestational-age fetus: prospective study. Ultrasound Obstet Gynecol. 2025. PMID: 40329845. doi:10.1002/uog.29237

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。